This inventor holds 14 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Medivir Ab, Medivir UK Ltd. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2025
Title: The Innovations of Magnus Nilsson: A Pioneer in Protease Inhibitors
Introduction: Magnus Nilsson, an accomplished inventor based in Huddinge, Sweden, has made significant contributions to the field of biotechnology. With a total of 13 patents to his name, Nilsson has demonstrated his commitment to innovation, particularly in the development of groundbreaking compounds.
Latest Patents: Among his recent inventions are advancements in protease inhibitors. His latest patents focus on compounds of the formula II, showcasing his dedication to creating novel enzymatic inhibitors that may have a profound impact on therapeutic applications.
Career Highlights: Throughout his career, Magnus has collaborated with notable companies such as Medivir AB and Medivir UK Ltd. His tenure at these organizations allowed him to refine his skills and contribute to the progress of pharmaceutical science, particularly in the realm of drug discovery and development.
Collaborations: Nilsson has worked alongside talented professionals, including Urszula Grabowska and Pia Kahnberg. Their collective expertise has propelled many innovative projects, fostering an environment ripe for scientific breakthroughs.
Conclusion: Magnus Nilsson's journey as an inventor exemplifies the spirit of innovation within the biotechnology sector. His contributions to the world of protease inhibitors not only highlight his exceptional skills but also promise advancements that could significantly enhance therapeutic options for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile